Substituted piperidines that increase p53 activity and the uses thereof

作者: Timothy J. Guzi , Stephane L. Bogen , Amin Nomeir , Malcolm Maccoss , Craig R. Gibeau

DOI:

关键词:

摘要: In its many embodiments, the present invention discloses novel compounds, as inhibitors of HDM2 protein, methods for preparing such pharmaceutical compositions including one or more treatment, prevention, inhibition, diseases associated with protein P53 using compounds compositions.

参考文章(331)
Nemichand Bherulal Jain, Pierina Chiesa, Yatindra Mohan Joshi, Pharmaceutical compositions having good stability ,(1989)
Sean M. Sullivan, Kenneth G. Draper, Method and reagent for treatment of animal diseases ,(1993)
Faizulla G. Kathawala, Sompong Wattanasin, Indene analogs of mevalonolactone and derivatives thereof ,(1985)
Charles J. Sherr, The Pezcoller lecture: cancer cell cycles revisited. Cancer Research. ,vol. 60, pp. 3689- 3695 ,(2000)
Malcolm Maccoss, Jeffrey J. Hale, Conrad P. Dorn, Sander G. Mills, Prodrugs of morpholine tachykinin receptor antagonists ,(1995)
James W. Malecha, Thomas D. Penning, Ish K. Khanna, Matthew J. Graneto, Julie M. Miyashiro, Donald J. Rogier, Paul W. Collins, John J. Talley, Roland S. Rogers, Stephen R. Bertenshaw, Jeffery S. Carter, Substituted pyrazolyl benzenesulfonamides ,(1993)
Gary Louis Bolton, Michael William Wilson, John Cooke Hodges, Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase ,(1995)
Barry A. Morgan, Thomas D. Gordon, Farnesyl transferase inhibitors ,(1997)